https://www.implantica.com/https://www.implantica.com/im-refluxstop/https://www.implantica.com/im-refluxstop/patients/gastrointestinal/https://www.implantica.com/im-refluxstop/professionals/gastrointestinal/https://www.implantica.com/im-refluxstop/scientific-publications-and-abstracts/https://www.implantica.com/product-pipeline/prioritized-products/https://www.implantica.com/product-pipeline/prioritized-products/urology/urinary-incontinence/https://www.implantica.com/product-pipeline/prioritized-products/gastrointestinal/obesity/https://www.implantica.com/product-pipeline/prioritized-products/ehealth/e-invivo/https://www.implantica.com/product-pipeline/follow-on-products/https://www.implantica.com/product-pipeline/follow-on-products/urology/urinary-retention/https://www.implantica.com/product-pipeline/follow-on-products/urology/erectile-dysfunction/https://www.implantica.com/product-pipeline/follow-on-products/gastrointestinal/ostomy/https://www.implantica.com/product-pipeline/follow-on-products/gastrointestinal/fecal-incontinence-stoma/https://www.implantica.com/product-pipeline/follow-on-products/ehealth/aorta-aneurysm/https://www.implantica.com/product-pipeline/future-pipeline-ip/https://www.implantica.com/innovations/technology-platform-overview/https://www.implantica.com/innovations/implantable-ehealth-platform/https://www.implantica.com/innovations/wireless-energizing-platform/https://www.implantica.com/innovations/patent-portfolio/https://www.implantica.com/search/https://www.implantica.com/about-implantica/company-profile/https://www.implantica.com/about-implantica/founder/https://www.implantica.com/about-implantica/board-of-directors/https://www.implantica.com/about-implantica/executive-management/https://www.implantica.com/about-implantica/mission-vision/https://www.implantica.com/about-implantica/sustainability/https://www.implantica.com/about-implantica/track-record/https://www.implantica.com/about-implantica/careers/https://www.implantica.com/about-implantica/contact/https://www.implantica.com/about-implantica/legal-notices/data-privacy/https://www.implantica.com/about-implantica/legal-notices/imprint/https://www.implantica.com/about-implantica/legal-notices/disclaimer/https://www.implantica.com/about-implantica/legal-notices/t-and-c/https://www.implantica.com/sidenav/https://www.implantica.com/media/press-releases/https://www.implantica.com/media/press-releases/2025/implantica-presenterar-forsta-kvartalet-for-2025-den-9-maj-kl-1500-cest/https://www.implantica.com/media/press-releases/2025/implantica-announces-15th-refluxstop-center-in-spain/https://www.implantica.com/media/press-releases/2025/implantica-tillkannager-15e-refluxstop-centret-i-spanien/https://www.implantica.com/media/press-releases/2025/implantica-publishes-interim-report-january-march-2025-q1/https://www.implantica.com/media/press-releases/2025/implantica-publicerar-delarsrapport-januari--mars-2025-q1/https://www.implantica.com/media/press-releases/2025/bulletin-from-the-annual-general-meeting-of-implantica-ag/https://www.implantica.com/media/press-releases/2025/implanticas-refluxstop-stimulerar-intensiv-dialog-pa-ddw-varldens-storsta-konferens-om-matsmaltningssjukdomar-som-halls-i-usa/https://www.implantica.com/media/press-releases/2025/implanticas-refluxstop-stimulates-intensive-dialogue-at-ddw-the-worlds-largest-digestive-disease-conference-held-in-the-u-s-/https://www.implantica.com/media/press-releases/2025/implantica-announces-that-uk-nice-has-published-positive-recommendations-for-the-refluxstop-procedure-in-the-nhs-public-hospitals/https://www.implantica.com/media/press-releases/2025/implantica-meddelar-att-brittiska-nice-har-publicerat-positiva-rekommendationer-for-refluxstop-proceduren-i-nhss-offentliga-sjukhus/https://www.implantica.com/media/press-releases/2025/implantica-tillkannager-en-ny-schweizisk-studie-med-99-refluxstop-patienter-jamforande-sma-och-stora-brack-i-magmunnen-bekraftande-de-utmarkta-langsiktiga-resultaten/https://www.implantica.com/media/press-releases/2025/implantica-announces-new-real-world-swiss-study-on-99-refluxstop-patients-comparing-small-and-large-hiatal-hernia-confirming-equally-excellent-long-term-results/https://www.implantica.com/media/press-releases/2025/implantica-announces-successful-uk-refluxstop-users-meeting-addressing-growing-demand-after-the-final-and-positive-uk-nice-recommendations-on-use-of-refluxstop-in-nhs-public-hospitals/https://www.implantica.com/media/press-releases/2025/implantica-meddelar-framgangsrikt-anvandarmote-for-refluxstop-i-uk-aven-adresserar-den-okade-efterfragan-efter-slutgiltigt-positiva-dekret-fran-nice-om-anvandandet-av-refluxstop-i-publika-nhs-sjukhus/https://www.implantica.com/media/press-releases/2025/implantica-submits-the-last-and-final-module-3-of-the-fda-pma-application-for-refluxstop-for-us-market-approval/https://www.implantica.com/media/press-releases/2025/implantica-lamnar-in-den-sista-och-slutliga-modul-3-av-sin-fda-pma-ansokan-for-refluxstop-for-godkannande-pa-den-amerikanska-marknaden/https://www.implantica.com/media/press-releases/2025/implantica-tillkannager-publiceringen-av-resultaten-fran-den-banbrytande-refluxstop-femariga-kliniska-studien-som-visar-utmarkta-langsiktiga-resultat/https://www.implantica.com/media/press-releases/2025/implantica-announces-publication-of-the-landmark-refluxstop-5-year-clinical-study-results-demonstrating-excellent-long-term-success/https://www.implantica.com/media/press-releases/2025/implantica-announces-second-publication-of-groundbreaking-5-year-results-from-the-landmark-refluxstop-clinical-study/https://www.implantica.com/media/press-releases/2025/implantica-tillkannager-en-ny-milstolpe-med-andra-publiceringen-av-de-banbrytande-5-arsresultat-fran-refluxstops-kliniska-studie/https://www.implantica.com/media/press-releases/2025/implantica-presents-the-second-quarter-2025-on-august-14-at-1500-cest/https://www.implantica.com/media/press-releases/2025/implantica-presenterar-andra-kvartalet-for-2025-den-14-augusti-kl-1500-cest/https://www.implantica.com/media/press-releases/2025/implantica-finishes-new-multi-cavity-production-tool-for-refluxstop-to-support-manufacturing-ramp-up-in-the-u-s-pending-fda-approval/https://www.implantica.com/media/press-releases/2025/implantica-fardigstaller-nytt-tillverkningsverktyg-med-flera-kaviteter-for-refluxstop-for-att-stodja-en-produktions-okningen-i-usa-i-vantan-pa-godkannande-fran-fda/https://www.implantica.com/media/press-releases/2025/implantica-publishes-interim-report-january-june-2025-q2/https://www.implantica.com/media/press-releases/2025/implantica-publicerar-delarsrapport-januari--juni-2025-q2/https://www.implantica.com/media/press-releases/2025/implantica-presents-the-first-quarter-2025-on-may-9-at-1500-cest/https://www.implantica.com/media/press-releases/2025/implantica-publishes-annual-report-2024/https://www.implantica.com/media/press-releases/2025/notice-of-annual-general-meeting-of-implantica-ag/https://www.implantica.com/media/press-releases/2025/implantica-tillkannager-en-nyligen-publicerad-verklig-studie-fran-tyskland-som-forstarker-de-utmarkta-resultaten-av-refluxstop/https://www.implantica.com/media/press-releases/2025/implantica-oppnar-ett-nytt-refluxstop-center-i-en-ny-region-i-spanien-for-att-mota-den-snabbt-vaxande-efterfragan/https://www.implantica.com/media/press-releases/2025/implantica-announces-a-newly-published-real-world-study-from-germany-reinforcing-the-excellent-refluxstop-results/https://www.implantica.com/media/press-releases/2025/implantica-opens-a-new-refluxstop-center-in-a-new-region-of-spain-addressing-the-fast-growing-demand/https://www.implantica.com/media/press-releases/2025/implanticas-refluxstop-garners-strong-interest-at-sages/https://www.implantica.com/media/press-releases/2025/implanticas-refluxstop-vacker-stort-intresse-vid-sages/https://www.implantica.com/media/press-releases/2025/implantica-tillkannager-ytterligare-expansion-av-refluxstop-kompetenscenter-och-patienttillgang-i-spanien/https://www.implantica.com/media/press-releases/2025/implantica-ramps-up-production-with-10-000-refluxstop-units-in-preparation-for-u-s-launch-pending-fda-pma-approval/https://www.implantica.com/media/press-releases/2025/implantica-okar-produktionen-med-10000-refluxstop-enheter-infor-lanseringen-i-usa-i-vantan-pa-pma-godkannande-fran-fda/https://www.implantica.com/media/press-releases/2025/implantica-announces-the-payment-of-share-rewards-based-on-the-agm-approved-share-based-incentive-program-as-a-directed-share-issue-of-own-shares-of-the-company-without-consideration/https://www.implantica.com/media/press-releases/2025/implantica-offentliggor-utbetalning-av-aktietilldelningar-baserade-pa-det-av-bolagsstamman-godkanda-aktierelaterade-incitamentsprogrammet-genom-en-riktad-emission-av-egna-aktier-bolaget-utan-betalning/https://www.implantica.com/media/press-releases/2025/implanticas-refluxstop-sparks-strong-excitement-at-the-american-foregut-society-meeting-ahead-of-pending-us-fda-approval/https://www.implantica.com/media/press-releases/2025/implanticas-refluxstop-vacker-stor-entusiasm-vid-american-foregut-society-motet-infor-det-kommande-godkannandet-av-amerikanska-fda/https://www.implantica.com/media/press-releases/2025/implantica-announces-u-s-fda-has-provided-feedback-on-the-final-refluxstop-pma-submission-module-3/https://www.implantica.com/media/press-releases/2025/implantica-meddelar-att-amerikanska-fda-har-aterkopplat-pa-den-finala-modulen-i-refluxstops-pma-ansokan-modul-3/https://www.implantica.com/media/press-releases/2025/implantica-steps-up-to-close-the-treatment-gap-with-refluxstop-as-main-device-competitor-exits-europe-and-the-uk/https://www.implantica.com/media/press-releases/2025/implantica-trappar-upp-for-att-fylla-behandlingsgapet-med-refluxstop-nar-primara-implantat-konkurrenten-lamnar-europa-och-storbritannien/https://www.implantica.com/media/press-releases/2025/implantica-successfully-completes-mdsap-recertification-audit/https://www.implantica.com/media/press-releases/2025/implantica-framgangsrikt-slutfor-sin-mdsap-recertifieringsrevision/https://www.implantica.com/media/press-releases/2025/implantica-completes-fda-100-day-meeting-for-refluxstop-pma-application/https://www.implantica.com/media/press-releases/2025/implantica-avslutar-fdas-100-dagarsmote-for-refluxstop-pma-ansokan/https://www.implantica.com/media/press-releases/2025/implantica-presents-the-third-quarter-2025-on-october-31-at-1500-cet/https://www.implantica.com/media/press-releases/2025/implantica-presenterar-tredje-kvartalet-for-2025-den-31-oktober-kl-1500-cet/https://www.implantica.com/media/press-releases/2025/implantica-publishes-interim-report-january-september-2025-q3/https://www.implantica.com/media/press-releases/2025/implantica-publicerar-delarsrapport-januari--september-2025-q3/https://www.implantica.com/media/press-releases/2025/refluxstop-takes-center-stage-at-2025-european-foregut-society-meeting/https://www.implantica.com/media/press-releases/2025/refluxstop-star-i-centrum-vid-european-foregut-society-motet-2025/https://www.implantica.com/media/press-releases/2025/refluxstop-utnamnt-till-bast-i-sin-klass-vid-japan-foregut-conference-efter-presentation-av-5-ars-data-och-omfattande-sakerhetskohort-for-120-ledande-kirurger/https://www.implantica.com/media/press-releases/2025/refluxstop-best-in-class-at-japan-foregut-conference-as-5-year-data-and-extensive-safety-cohort-is-presented-to-120-leading-surgeons/https://www.implantica.com/media/press-releases/2025/implantica-strengthens-market-expansion-as-italys-leading-careggi-university-hospital-in-florence-introduces-refluxstop/https://www.implantica.com/media/press-releases/2025/implantica-starker-sin-marknadsexpansion-nar-italiens-ledande-universitetssjukhus-careggi-i-florens-introducerar-refluxstop/https://www.implantica.com/media/press-releases/2025/implantica-announces-further-expansion-of-refluxstop-centers-of-excellence-and-patient-access-in-spain/https://www.implantica.com/media/press-releases/2025/implantica-publicerar-bokslutskommunike-januari-december-2024-q4/https://www.implantica.com/media/press-releases/2025/implantica-publishes-year-end-report-january-december-2024-q4/https://www.implantica.com/media/press-releases/2025/implantica-announces-positive-feedback-received-from-u-s-fda-of-the-refluxstop-pma-module-2-submission/https://www.implantica.com/media/press-releases/2025/implantica-meddelar-att-man-fatt-positiv-feedback-fran-u-s-fda-pa-refluxstop-pma-module-2-ansokan/https://www.implantica.com/media/press-releases/2025/implantica-announces-module-1-is-accepted-and-closed-by-fda-in-the-pma-application-for-refluxstop/https://www.implantica.com/media/press-releases/2025/implantica-meddelar-att-modul-1-har-accepterats-och-avslutats-av-fda-i-pma-ansokan-for-refluxstop/https://www.implantica.com/media/press-releases/2025/implantica-presents-the-year-end-report-q4-2024-on-february-14-at-1500-cet/https://www.implantica.com/media/press-releases/2025/implantica-presenterar-bokslutskommunike-q4-2024-den-14-februari-kl-1500-cet/https://www.implantica.com/media/press-releases/2025/implantica-announces-onboarding-of-the-world-leading-la-paz-university-hospital-spain/https://www.implantica.com/media/press-releases/2025/implantica-tillkannager-onboarding-av-det-varldsledande-universitetssjukhuset-la-paz-i-spanien/https://www.implantica.com/media/press-releases/2025/implantica-meddelar-att-det-forsta-gi-fokuserade-refluxstop-utbildningsmotet-har-genomforts-pa-ett-prestigefyllt-nhs-sjukhus-i-storbritannien/https://www.implantica.com/media/press-releases/2025/implantica-announces-completion-of-first-gi-focused-refluxstop-educational-meeting-by-a-prestigious-nhs-hospital-in-the-uk/https://www.implantica.com/media/press-releases/2025/implantica-announces-new-exceptional-published-data-from-the-largest-real-world-study-from-germany/https://www.implantica.com/media/press-releases/2025/implantica-tillkannager-nya-exceptionella-publicerade-data-fran-den-storsta-realtidsstudien-fran-tyskland/https://www.implantica.com/media/press-releases/2024/implantica-completes-human-factors-validation-study-for-refluxstop-as-part-of-the-us-fda-premarket-approval-process/https://www.implantica.com/media/press-releases/2024/implantica-fortsatter-tysk-expansion-med-ytterligare-ett-refluxcenter-i-berlin/https://www.implantica.com/media/press-releases/2024/implanticas-refluxstop-ar-nu-tillganglig-pa-7-sjukhus-i-spanien-och-tva-nya-centers-of-excellence-har-tillkommit/https://www.implantica.com/media/press-releases/2024/implantica-submits-u-s-fda-premarket-approval-pma-application-for-refluxstop-first-module/https://www.implantica.com/media/press-releases/2024/implantica-publishes-interim-report-january-june-2024-q2/https://www.implantica.com/media/press-releases/2024/implantica-lanserar-refluxstop-avancerat-utbildningsprogram-i-spanien/https://www.implantica.com/media/press-releases/2024/implantica-tillkannager-ett-attonde-refluxstop-center-of-excellence-i-italien/https://www.implantica.com/media/press-releases/2024/implantica-announces-new-health-economics-data-publication-showing-refluxstops-superior-cost-effectiveness-for-the-swiss-healthcare-system/https://www.implantica.com/media/press-releases/2024/implantica-delar-en-viktig-granskningsartikel-om-nissen-fundoplikation-som-standardbehandling-for-antirefluxkirurgi-mot-bakgrund-av-de-nyligen-offentliggjorda-utmarkta-refluxstop-5-arsresultat/https://www.implantica.com/media/press-releases/2024/implantica-announces-another-major-public-hospital-purchase-agreement-win-in-italy-further-strengthening-refluxstops-broader-acceptance-in-public-healthcare-systems-in-europe/https://www.implantica.com/media/press-releases/2024/implantica-vinner-annu-en-offentlig-upphandling-av-refluxstop-i-europa-denna-gang-i-spanien-med-hospital-universitario-de-getafe/https://www.implantica.com/media/press-releases/2024/implantica-announces-finalization-of-remarkable-5-year-pivotal-ce-mark-study-results-and-gears-up-for-the-module-2-submission-of-pma-application-to-fda-for-refluxstop/https://www.implantica.com/media/press-releases/2024/implantica-genomfor-det-forsta-nationella-refluxstop-anvandarmotet-med-21-deltagande-kirurger-1-5-ar-efter-lanseringen-i-italien/https://www.implantica.com/media/press-releases/2024/implantica-welcomes-23-top-anti-reflux-surgeons-from-17-leading-centers-in-the-first-user-meeting-in-spain-1-5-years-post-country-launch/https://www.implantica.com/media/press-releases/2024/implantica-publicerar-delarsrapport-januari--mars-2024-q1/https://www.implantica.com/media/press-releases/2024/implantica-tecknar-inkopsavtal-for-ytterligare-ett-offentligt-italienskt-sjukhus-vilket-ger-ytterligare-forstarkning-av-en-bredare-acceptans-for-refluxstop-inom-den-offentliga-sjukvarden-i-europa/https://www.implantica.com/media/press-releases/2024/implantica-meddelar-att-kliniska-data-fran-normal-sjukvard-pa-over-200-patienter-som-behandlats-vid-fem-refluxstop-center-i-europa-presenterade-vid-sages-i-cleveland/https://www.implantica.com/media/press-releases/2024/implantica-submits-fda-pma-application-clinical-module-2-for-refluxstop-for-u-s-market-approval/https://www.implantica.com/media/press-releases/2024/implantica-continues-to-expand-in-germany-with-another-reflux-center-of-excellence-in-berlin/https://www.implantica.com/media/press-releases/2024/implantica-announces-further-expansion-of-refluxstop-access-in-the-uk-nhs-public-hospital-network/https://www.implantica.com/media/press-releases/2024/implantica-tillkannager-ytterligare-en-viktig-refluxstop-studie-fran-real-world-som-visar-utmarkta-resultat-och-som-publicerats-i-en-prestigefylld-topptidskrift/https://www.implantica.com/media/press-releases/2024/implanticas-refluxstop-is-now-available-in-seven-hospitals-in-spain-adding-two-new-centers-of-excellence/https://www.implantica.com/media/press-releases/2024/bulletin-from-the-annual-general-meeting-of-implantica-ag/https://www.implantica.com/media/press-releases/2024/implantica-presenterar-andra-kvartalet-for-2024-den-21-augusti-kl-1500-cest/https://www.implantica.com/media/press-releases/2024/implantica-starker-den-strategiska-expansionen-av-refluxstop-med-ytterligare-ett-viktigt-universitetssjukhus-i-tyskland-med-flera-andra-i-pipeline/https://www.implantica.com/media/press-releases/2024/implantica-inkluderas-i-nasdaqs-first-north-25-index/https://www.implantica.com/media/press-releases/2024/implantica-tillkannager-slutforandet-av-anmarkningsvarda-5-ariga-pivotala-studieresultat-fran-var-ce-studie-och-vaxlar-upp-for-modul-2-inlamningen-av-pma-ansokan-till-fda-for-refluxstop/https://www.implantica.com/media/press-releases/2024/implantica-to-be-included-in-nasdaqs-first-north-25-index/https://www.implantica.com/media/press-releases/2024/implantica-presents-the-fourth-quarter-2023-on-february-16-at-1500-cet/https://www.implantica.com/media/press-releases/2024/implantica-presenterar-forsta-kvartalet-for-2024-den-15-maj-kl-1500-cest/https://www.implantica.com/media/press-releases/2024/implantica-presents-the-first-quarter-2024-on-may-15-at-1500-cest/https://www.implantica.com/media/press-releases/2024/implanticas-refluxstop-procedure-now-available-in-norway/https://www.implantica.com/media/press-releases/2024/implantica-announces-first-refluxstop-public-tender-win-paving-the-way-for-permanent-reimbursement-in-italy/https://www.implantica.com/media/press-releases/2024/implantica-announces-real-world-clinical-data-from-over-200-patients-treated-across-five-refluxstop-centers-in-europe-presented-at-sages-in-cleveland/https://www.implantica.com/media/press-releases/2024/implantica-tillkannager-ytterligare-expansion-av-refluxstops-tillganglighet-i-det-brittiska-publika-nhs-sjukhusnatverket/https://www.implantica.com/media/press-releases/2024/implantica-announces-two-new-refluxstop-university-hospitals-in-spain-leading-to-10-active-centers-and-many-more-to-join-soon/https://www.implantica.com/media/press-releases/2024/implantica-lamnar-in-fdas-pma-ansokan-clinical-module-2-for-refluxstop-for-marknadsgodkannande-i-usa/https://www.implantica.com/media/press-releases/2024/implanticas-refluxstop-ingar-i-sju-presentationer-accepterade-vid-usas-storsta-gi-konferens-sages/https://www.implantica.com/media/press-releases/2024/implantica-slutfor-valideringsstudie-i-manskliga-faktorer-for-handhavandet-under-refluxstop-proceduren-som-del-av-fdas-premarket-approval-process-i-usa/https://www.implantica.com/media/press-releases/2024/implantica-wins-another-refluxstop-public-tender-in-europe-this-time-in-spain-with-hospital-universitario-de-getafe/https://www.implantica.com/media/press-releases/2024/implantica-publishes-year-end-report-january-december-2023-q4/https://www.implantica.com/media/press-releases/2024/implantica-strengthens-the-strategic-refluxstop-expansion-with-the-addition-of-yet-another-key-university-hospital-in-germany-with-several-more-in-the-pipeline/https://www.implantica.com/media/press-releases/2024/implantica-tillkannager-ett-mycket-framgangsrikt-2024-american-foregut-society-mote-dar-refluxstop-fick-anmarkningsvard-forlanseringsfeedback-fran-marknaden/https://www.implantica.com/media/press-releases/2024/implantica-announces-continuing-progress-in-modular-pma-application-to-fda-for-refluxstop/https://www.implantica.com/media/press-releases/2024/implantica-meddelar-kontinuerliga-framsteg-i-modulara-pma-ansokan-till-fda-for-refluxstop/https://www.implantica.com/media/press-releases/2024/implantica-presents-the-third-quarter-2024-on-november-15-at-1500-cest/https://www.implantica.com/media/press-releases/2024/implantica-sorjer-styrelseledamoten-prof-dr-klaus-neftels-bortgang/https://www.implantica.com/media/press-releases/2024/implantica-fordjupar-marknadspenetrationen-i-italien-med-tillagget-av-det-nionde-refluxstop-center-of-excellence-med-flera-sjukhus-pa-vag-att-starta-inom-kort/https://www.implantica.com/media/press-releases/2024/implantica-deepens-market-penetration-in-italy-with-the-addition-of-the-ninth-refluxstop-center-of-excellence-and-several-lined-up-to-start-near-term/https://www.implantica.com/media/press-releases/2024/implantica-lamnar-in-fda-ansokan-for-refluxstop-us-premarket-approval-pma-submission-first-module-for-att-erhalla-godkannande-att-salja-refluxstop-i-usa/https://www.implantica.com/media/press-releases/2024/implantica-tillkannager-en-ny-publicerad-halsoekonomisk-analys-vilken-visar-refluxstops-overlagsna-kostnadseffektivitet-for-det-schweiziska-sjukvardssystemet/https://www.implantica.com/media/press-releases/2024/implantica-conducts-first-national-refluxstop-user-meeting-with-21-participating-surgeons-1-5-years-after-launch-in-italy/https://www.implantica.com/media/press-releases/2024/implanticas-refluxstop-now-available-in-munich/https://www.implantica.com/media/press-releases/2024/implanticas-refluxstop-nu-tillganglig-i-munchen/https://www.implantica.com/media/press-releases/2024/implantica-announces-another-landmark-real-world-refluxstop-study-demonstrating-excellent-outcomes-published-in-a-prestigious-top-tier-journal/https://www.implantica.com/media/press-releases/2024/implantica-announces-highly-successful-2024-american-foregut-society-meeting-where-refluxstop-received-remarkable-pre-launch-market-feedback/https://www.implantica.com/media/press-releases/2024/implantica-tillkannager-tva-nya-refluxstop-universitetssjukhus-i-spanien-vilket-leder-till-10-aktiva-center-med-manga-fler-som-kommer-att-ansluta-inom-kort/https://www.implantica.com/media/press-releases/2024/implantica-valkomnar-23-framstaende-anti-refluxkirurger-fran-17-ledande-centra-till-det-forsta-anvandarmotet-i-spanien-1-5-ar-efter-lanseringen-i-landet/https://www.implantica.com/media/press-releases/2024/implantica-publishes-annual-report-2023/https://www.implantica.com/media/press-releases/2024/implantica-publishes-interim-report-january-september-2024-q3/https://www.implantica.com/media/press-releases/2024/implanticas-refluxstop-procedur-nu-tillganglig-i-norge/https://www.implantica.com/media/press-releases/2024/implantica-publicerar-delarsrapport-januari--september-2024-q3/https://www.implantica.com/media/press-releases/2024/implantica-announces-refluxstop-pivotal-4-year-study-results-published-in-the-prestigious-journal-surgical-endoscopy/https://www.implantica.com/media/press-releases/2024/implantica-offentliggor-utbetalning-av-aktietilldelningar-baserade-pa-av-bolagsstamman-godkanda-aktierelaterade-incitamentsprogrammet-genom-en-riktad-emission-av-egna-aktier-i-bolaget-utan-betalning/https://www.implantica.com/media/press-releases/2024/implantica-announces-the-payment-of-share-rewards-based-on-the-agm-approved-share-based-incentive-program-as-a-directed-share-issue-of-own-shares-of-the-company-without-consideration/https://www.implantica.com/media/press-releases/2024/notice-of-annual-general-meeting-of-implantica-ag/https://www.implantica.com/media/press-releases/2024/implantica-publishes-interim-report-january-march-2024-q1/https://www.implantica.com/media/press-releases/2024/implantica-presenterar-tredje-kvartalet-for-2024-den-15-november-kl-1500-cet/https://www.implantica.com/media/press-releases/2024/implantica-mourns-the-death-of-board-member-prof-dr-klaus-neftel/https://www.implantica.com/media/press-releases/2024/implanticas-refluxstop-featured-in-seven-presentations-accepted-at-the-largest-us-gi-conference-sages/https://www.implantica.com/media/press-releases/2024/implantica-tillkannager-den-forsta-offentliga-upphandlingvinsten-for-refluxstop-vilket-banar-vag-for-permanent-kostnadsersattning-i-italien/https://www.implantica.com/media/press-releases/2024/implantica-launches-refluxstop-advanced-education-program-in-spain/https://www.implantica.com/media/press-releases/2024/implantica-publicerar-bokslutskommunike--januari-december-2023-q4/https://www.implantica.com/media/press-releases/2024/implantica-tillkannager-utmarkta-refluxstop-sjukhus-initierade-studieresultat-som-publicerats-i-scientific-reports-en-nature-tidskrift/https://www.implantica.com/media/press-releases/2024/implantica-announces-the-eighth-refluxstop-center-of-excellence-in-italy/https://www.implantica.com/media/press-releases/2024/implantica-shares-a-landmark-review-article-on-standard-of-care-nissen-fundoplication-anti-reflux-surgery-in-light-of-the-recently-announced-excellent-refluxstoptm-5-year-results/https://www.implantica.com/media/press-releases/2024/implantica-tillkannager-utmarkta-data-fran-en-oberoende-studie-med-158-refluxstop-patienter-fran-tva-center-i-tyskland--presenterade-vid-augis-konferensen-i-storbritannien/https://www.implantica.com/media/press-releases/2024/implantica-meddelar-att-resultaten-fran-den-pivotala-4-arsstudien-av-refluxstop-har-publicerats-i-den-ansedda-tidskriften-surgical-endoscopy/https://www.implantica.com/media/press-releases/2024/implantica-announces-excellent-refluxstop-investigator-initiated-study-results-published-in-scientific-reports-a-nature-journal/https://www.implantica.com/media/press-releases/2024/implantica-presenterar-fjarde-kvartalet-for-2023-den-16-februari-kl-1500-cet/https://www.implantica.com/media/press-releases/2024/implantica-presents-the-second-quarter-2024-on-august-21-at-1500-cest/https://www.implantica.com/media/press-releases/2024/implantica-announces-excellent-data-from-an-independent-study-of-158-refluxstop-patients-from-two-centers-in-germany-presented-at-the-augis-meeting-in-uk/https://www.implantica.com/media/press-releases/2024/implantica-publicerar-delarsrapport-januari--juni-2024-q2/https://www.implantica.com/media/press-releases/2023/implantica-further-expands-its-commercial-footprint-in-italy/https://www.implantica.com/media/press-releases/2023/implantica-takes-a-big-step-forward-at-its-2nd-annual-refluxstop-users-meeting/https://www.implantica.com/media/press-releases/2023/implanticas-refluxstoptm-a-promising-new-procedure-for-chronic-acid-reflux-offered-for-the-first-time-in-the-nhs-in-uk/https://www.implantica.com/media/press-releases/2023/implanticas-halsoekonomiska-forskning-om-refluxstoptm-som-visar-superior-kostnadseffektivitet-har-fatt-ett-stort-erkannande-vid-ispor-den-varldsledande-europeiska-halsoekonomikonferensen/https://www.implantica.com/media/press-releases/2023/implantica-presenterar-tredje-kvartalet-for-2023-den-22-november-kl-1500-cet/https://www.implantica.com/media/press-releases/2023/save-the-date-implanticas-kapitalmarknadsdag-2023/https://www.implantica.com/media/press-releases/2023/implantica-meddelar-att-tva-oberoende-kirurger-presenterade-patientdata-for-refluxstop-vid-2023-ars-arliga-schweiziska-kirurgkollegium-scs/https://www.implantica.com/media/press-releases/2023/inbjudan-till-kapitalmarknadsdag-i-stockholm-den-26-september-2023/https://www.implantica.com/media/press-releases/2023/invitation-to-implanticas-cmd-in-stockholm-on-september-26-2023/https://www.implantica.com/media/press-releases/2023/implantica-presents-the-second-quarter-2023-on-august-24-at-1500-cet/https://www.implantica.com/media/press-releases/2023/implantica-announces-two-independent-scientific-presentations-on-refluxstop-from-the-2023-annual-isde-conference/https://www.implantica.com/media/press-releases/2023/implanticas-refluxstoptm--en-lovande-ny-operation-for-ihallande-sura-uppstotningar--erbjuds-for-forsta-gangen-hos-nhs-i-storbritannien/https://www.implantica.com/media/press-releases/2023/implantica-announces-live-surgery-with-refluxstop-attended-by-nearly-2000-surgeons-and-streamed-by-up-to-100000-online/https://www.implantica.com/media/press-releases/2023/implantica-espande-ulteriormente-la-sua-presenza-commerciale-in-italia/https://www.implantica.com/media/press-releases/2023/implantica-publicerar-delarsrapport-januari---september-2023-q3/https://www.implantica.com/media/press-releases/2023/implantica-adderar-ytterligare-refluxstop-center-i-spanien/https://www.implantica.com/media/press-releases/2023/implantica-receives-mdr-certification-for-refluxstop/https://www.implantica.com/media/press-releases/2023/implanticas-refluxstop-far-stort-genomslag-vid-det-ledande-arliga-motet-for-european-foregut-society/https://www.implantica.com/media/press-releases/2023/implantica-publishes-interim-report-january--september-2023-q3/https://www.implantica.com/media/press-releases/2023/implanticas-meddelar-att-refluxstop-proceduren-utfordes-live-infor-nastan-2000-kirurger-och-streamades-av-upp-till-100000-pa-natet/https://www.implantica.com/media/press-releases/2023/implantica-presents-the-third-quarter-2023-on-november-22-at-1500-cet/https://www.implantica.com/media/press-releases/2023/implantica-expanderar-i-italien/https://www.implantica.com/media/press-releases/2023/implantica-presenterar-andra-kvartalet-for-2023-den-24-augusti-kl-1500-cet/https://www.implantica.com/media/press-releases/2023/implantica-erhaller-mdr-certifiering-for-refluxstop/https://www.implantica.com/media/press-releases/2023/implanticas-refluxstop--made-a-substantial-impact-at-the-american-foregut-society-afs/https://www.implantica.com/media/press-releases/2023/implantica-tar-ett-stort-steg-framat-vid-sitt-andra-arliga-refluxstop-anvandarmote/https://www.implantica.com/media/press-releases/2023/implantica-reports-that-two-independent-surgeons-presented-their-refluxstop-patient-data-at-the-2023-annual-swiss-college-of-surgeons-congress-scs/https://www.implantica.com/media/press-releases/2023/save-the-date-implantica-capital-markets-day-2023/https://www.implantica.com/media/press-releases/2023/implanticas-refluxstop-makes-an-impact-at-the-leading-annual-european-foregut-society-meeting/https://www.implantica.com/media/press-releases/2023/implanticas-refluxstoptm-health-economic-research-showing-superior-cost-effectiveness-has-received-top-recognition-at-ispor-the-worlds-leading-european-health-economics-conference/https://www.implantica.com/media/press-releases/2023/implantica-announces-completion-of-first-refluxstop-procedures-by-the-president-of-the-european-foregut-society/https://www.implantica.com/media/press-releases/2023/implantica-adds-another-refluxstop-center-in-spain/https://www.implantica.com/media/press-releases/2023/implantica-publishes-interim-report-january--june-2023-q2/https://www.implantica.com/media/press-releases/2023/implanticas-refluxstop-gor-stort-avtryck-pa-american-foregut-society/https://www.implantica.com/media/press-releases/2023/implantica-kungor-tva-oberoende-vetenskapliga-presentationer-vid-isde-2023/https://www.implantica.com/media/press-releases/2023/implantica-tillkannager-slutforandet-av-de-forsta-refluxstop-procedurerna-av-ordforanden-for-european-foregut-society/https://www.implantica.com/media/press-releases/2023/implanticas-refluxstop-wins-medtop-techs-most-innovative-device-category-award/https://www.implantica.com/media/press-releases/2023/implanticas-refluxstop-vinner-medtop-techs-pris-som-mest-innovativa-medicinska-produkt/https://www.implantica.com/media/press-releases/2023/bulletin-from-the-annual-general-meeting-of-implantica-ag/https://www.implantica.com/media/press-releases/2023/implantica-announces-that-refluxstop-results-were-presented-at-the-ddw-conference-in-chicago/https://www.implantica.com/media/press-releases/2023/implantica-meddelar-att-refluxstop-resultat-presenterades-pa-ddw-konferensen-i-chicago/https://www.implantica.com/media/press-releases/2023/implantica-publishes-interim-report-january--march-2023-q1/https://www.implantica.com/media/press-releases/2023/implantica-publicerar-delarsrapport-januari---mars-2023-q1/https://www.implantica.com/media/press-releases/2023/implantica-recognized-among-the-50-admired-companies-to-watch-in-2023/https://www.implantica.com/media/press-releases/2023/implantica-erkant-som-ett-av-50-beundrade-foretag-2023-att-halla-ett-oga-pa/https://www.implantica.com/media/press-releases/2023/implantica-presents-the-first-quarter-2023-on-may-12-at-1500-cet/https://www.implantica.com/media/press-releases/2023/implantica-presenterar-forsta-kvartalet-for-2023-den-12-maj-kl-1500-cet/https://www.implantica.com/media/press-releases/2023/notice-of-annual-general-meeting-of-implantica-ag/https://www.implantica.com/media/press-releases/2023/implantica-announces-100th-refluxstop-procedure-completed-in-a-single-center-of-excellence-in-germany/https://www.implantica.com/media/press-releases/2023/implantica-meddelar-att-refluxstop-behandlingen-har-anvants-100-ganger-vid-en-ledande-refluxklinik-i-tyskland/https://www.implantica.com/media/press-releases/2023/implantica-publishes-annual-report-2022/https://www.implantica.com/media/press-releases/2023/implantica-publicerar-arsredovisning-2022/https://www.implantica.com/media/press-releases/2023/repurchase-of-implantica-ag-own-shares-during-week-15-2023/https://www.implantica.com/media/press-releases/2023/aterkop-av-implantica-ags-egna-aktier-under-vecka-15-2023/https://www.implantica.com/media/press-releases/2023/repurchase-of-implantica-ag-own-shares-until-april-6-2023/https://www.implantica.com/media/press-releases/2023/aterkop-av-implantica-ags-egna-aktier-fram-till-den-6-april-2023/https://www.implantica.com/media/press-releases/2023/implantica-announces-another-major-european-center-of-excellence-in-italy-starting-with-the-refluxstop-procedure/https://www.implantica.com/media/press-releases/2023/implanticas-refluxstop-lanseras-pa-ytterligare-ett-ledande-europeiskt-forskningscenter-i-italien/https://www.implantica.com/media/press-releases/2023/implantica-announces-dr-med-yves-borbely-presented-his-3-year-data-on-refluxstoptm-at-the-society-of-american-gastrointestinal-and-endoscopic-surgeons-sages/https://www.implantica.com/media/press-releases/2023/implantica-meddelar-att-dr-med-yves-borbely-presenterade-sina-3-ars-data-om-refluxstop-vid-society-of-american-gastrointestinal-and-endoscopic-surgeons-sages/https://www.implantica.com/media/press-releases/2023/implantica-lanserar-refluxstop-i-italien/https://www.implantica.com/media/press-releases/2023/implantica-launches-refluxstop-in-italy/https://www.implantica.com/media/press-releases/2023/implantica-presenterar-pa-redeyes-seminar-future-of-healthcare/https://www.implantica.com/media/press-releases/2023/implantica-presents-at-redeye-future-of-healthcare-seminar/https://www.implantica.com/media/press-releases/2023/implantica-to-repurchase-own-shares/https://www.implantica.com/media/press-releases/2023/implantica-aterkoper-egna-aktier/https://www.implantica.com/media/press-releases/2023/implantica-announces-refluxstop-launch-in-spain/https://www.implantica.com/media/press-releases/2023/implantica-meddelar-att-refluxstop-lanserats-i-spanien/https://www.implantica.com/media/press-releases/2023/implantica-publishes-year-end-report-january--december-2022-q4/https://www.implantica.com/media/press-releases/2023/implantica-publicerar-bokslutskommunike--januari-december-2022-q4/https://www.implantica.com/media/press-releases/2023/implantica-announces-refluxstop-launch-in-scandinavia/https://www.implantica.com/media/press-releases/2023/implantica-tillkannager-lansering-av-refluxstop-i-skandinavien/https://www.implantica.com/media/press-releases/2023/implantica-presents-the-fourth-quarter-2022-on-february-17-at-1500-cet/https://www.implantica.com/media/press-releases/2023/implantica-presenterar-fjarde-kvartalet-for-2022-den-17-februari-kl-1500-cet/https://www.implantica.com/media/press-releases/2023/implantica-has-successfully-completed-iso-13485-and-mdsap-recertifications/https://www.implantica.com/media/press-releases/2023/implantica-har-framgangsrikt-genomfort-omcertifieringar-enligt-iso-13485-och-mdsap/https://www.implantica.com/media/press-releases/2022/implantica-to-present-at-digital-medicine--medtech-showcase-2022/https://www.implantica.com/media/press-releases/2022/implantica-publishes-interim-report-q3-2022/https://www.implantica.com/media/press-releases/2022/implantica-publicerar-delarsrapport-q3-2022/https://www.implantica.com/media/press-releases/2022/implantica-receives-ghps-2022-most-innovative-medtech-company-award--central-europe/https://www.implantica.com/media/press-releases/2022/implantica-far-ghps-pris-for-det-mest-innovativa-medtech-foretaget-2022-i-centraleuropa/https://www.implantica.com/media/press-releases/2022/implantica-presents-refluxstops-health-economic-impact-at-ispor-europe-2022/https://www.implantica.com/media/press-releases/2022/implantica-presenterar-refluxstops-halsoekonomiska-paverkan-vid-ispor-europe-2022/https://www.implantica.com/media/press-releases/2022/implantica-presents-the-third-quarter-2022-on-november-15-at-1500-cet/https://www.implantica.com/media/press-releases/2022/implantica-presenterar-tredje-kvartalet-for-2022-den-15-november-kl-1500-cet/https://www.implantica.com/media/press-releases/2022/implanticas-innovative-refluxstop--treatment-solution-showcased-at-the-annual-european-foregut-society-efs-meeting/https://www.implantica.com/media/press-releases/2022/implanticas-innovativa-behandlingslosning-refluxstoptm-presenterades-vid-det-arliga-motet-med-european-foregut-society-efs/https://www.implantica.com/media/press-releases/2022/implantica-announces-spire-manchester-hospital-in-uk-begins-operating-with-refluxstop/https://www.implantica.com/media/press-releases/2022/implantica-meddelar-att-spire-manchester-hospital-i-storbritannien-startat-att-operera-med-refluxstop/https://www.implantica.com/media/press-releases/2022/implantica-publishes-interim-report-q2-2022/https://www.implantica.com/media/press-releases/2022/implantica-publicerar-delarsrapport-q2-2022/https://www.implantica.com/media/press-releases/2022/implantica-presents-a-robust-health-economic-analysis-of-refluxstop-conducted-by-university-of-york-uk/https://www.implantica.com/media/press-releases/2022/implantica-presenterar-en-robust-halsoekonomisk-utvardering-av-refluxstop-utford-av-university-of-york-storbritannien/https://www.implantica.com/media/press-releases/2022/implantica-presenterar-andra-kvartalet-for-2022-den-23-augusti-kl-1500-cest/https://www.implantica.com/media/press-releases/2022/implantica-presents-the-second-quarter-2022-on-august-23-at-1500-cest/https://www.implantica.com/media/press-releases/2022/implantica-engages-pareto-securities-as-liquidity-provider/https://www.implantica.com/media/press-releases/2022/implantica-anlitar-pareto-securities-som-lividitetsgarant/https://www.implantica.com/media/press-releases/2022/implantica-receives-frost--sullivans-2022-european-technology-innovation-leadership-award-for-refluxstop--an-innovative-treatment-solution-for-acid-reflux/https://www.implantica.com/media/press-releases/2022/implantica-erhaller-frost--sullivans-2022-european-technology-innovation-leadership-award-for-refluxstop---en-innovativ-behandlingslosning-for-sura-uppstotningar/https://www.implantica.com/media/press-releases/2022/implantica-publishes-interim-report-q1-january--march-2022/https://www.implantica.com/media/press-releases/2022/implantica-publicerar-delarsrapporten-q1-januari-mars-2022/https://www.implantica.com/media/press-releases/2022/bulletin-from-the-annual-general-meeting-in-implantica-ag/https://www.implantica.com/media/press-releases/2022/implantica-presents-the-first-quarter-2022-on-may-11-at-1500-cest/https://www.implantica.com/media/press-releases/2022/implantica-presenterar-forsta-kvartalet-for-2022-den-11-maj-kl-1500-cest/https://www.implantica.com/media/press-releases/2022/notice-of-annual-general-meeting-of-implantica-ag/https://www.implantica.com/media/press-releases/2022/implantica-publishes-annual-report-2021/https://www.implantica.com/media/press-releases/2022/implantica-publicerar-arsredovisning-2021/https://www.implantica.com/media/press-releases/2022/implantica-presenterar-pa-aktiedagen-stockholm-den-15-mars-kl-1830/https://www.implantica.com/media/press-releases/2022/implantica-presents-at-aktiedagen-stockholm-on-march-15-at-1830/https://www.implantica.com/media/press-releases/2022/implantica-announces-launch-of-refluxstop-in-uk/https://www.implantica.com/media/press-releases/2022/implantica-lanserar-refluxstop-i-storbritannien/https://www.implantica.com/media/press-releases/2022/implantica-announces-filing-of-comprehensive-ehealth-patent-applications-for-its-platform-technology/https://www.implantica.com/media/press-releases/2022/implantica-meddelar-att-man-har-lamnat-in-omfattande-patentansokningar-for-sin-e-halsoplattform/https://www.implantica.com/media/press-releases/2022/implantica-publishes-year-end-report-january--december-2021/https://www.implantica.com/media/press-releases/2022/implantica-publicerar-bokslutskommunike--januari-december-2021/https://www.implantica.com/media/press-releases/2022/implantica-presents-the-fourth-quarter-2021-on-february-18-at-1500-cet/https://www.implantica.com/media/press-releases/2022/implantica-presenterar-fjarde-kvartalet-for-2021-den-18-februari-kl-1500-cet/https://www.implantica.com/media/press-releases/2022/implantica-conducts-innovative-ehealth-workshop/https://www.implantica.com/media/press-releases/2022/implantica-genomfor-en-innovativ-workshop-om-e-halsa/https://www.implantica.com/media/press-releases/2022/implantica-taps-former-medtronic-executive-paul-mead-for-coo-role/https://www.implantica.com/media/press-releases/2022/implantica-rekryterar-paul-mead-tidigare-toppchef-inom-medtronic-som-coo/https://www.implantica.com/media/press-releases/2022/implantica-presenterar-pa-digital-medicine--medtech-showcase-2022/https://www.implantica.com/media/press-releases/2021/implantica-successfully-performs-cadaver-implantations-of-pipeline-products-and-several-related-tests-at-the-cadaver-lab/https://www.implantica.com/media/press-releases/2021/implantica-genomfor-framgangsrika-kadaverimplantationer-av-ett-fletal-pipelineprodukter-med-multipla-relaterade-tester-i-kadaverlabbet/https://www.implantica.com/media/press-releases/2021/implantica-publishes-interim-report-q3-january--september-2021/https://www.implantica.com/media/press-releases/2021/implantica-publicerar-delarsrapporten-q3-januari-september-2021/https://www.implantica.com/media/press-releases/2021/implantica-expands-executive-team-with-new-chief-market-access--strategy-officer/https://www.implantica.com/media/press-releases/2021/implantica-utokar-ledningsgruppen-med-en-ny-chief-market-access--strategy-officer/https://www.implantica.com/media/press-releases/2021/implantica-presents-the-third-quarter-2021-on-november-24-at-1500-cet/https://www.implantica.com/media/press-releases/2021/implantica-presenterar-tredje-kvartalet-for-2021-den-24-november-kl-1500-cet/https://www.implantica.com/media/press-releases/2021/implantica-takes-a-big-step-forward-in-its-refluxstop-us-approval-process-discussions-with-fda/https://www.implantica.com/media/press-releases/2021/implantica-tar-ett-stort-kliv-framat-i-diskussionerna-med-fda-gallande-den-amerikanska-godkannandeprocessen-for-refluxstop/https://www.implantica.com/media/press-releases/2021/implantica-announces-initial-uk-surgical-training-for-refluxstop/https://www.implantica.com/media/press-releases/2021/implantica-tillkannager-den-forsta-kirurgiska-utbildningen-i-storbritannien-for-refluxstop/https://www.implantica.com/media/press-releases/2021/nyremittering-protokoll-fran-den-extra-bolagsstamman-i-implantica-ag---tillgangar-pa-117-miljoner-euro-har-tillforts-implantica-utan-ersattning-i-form-av-pengar-eller-aktier/https://www.implantica.com/media/press-releases/2021/protokoll-fran-den-extra-bolagsstamman-i-implantica-ag---tillgangar-pa-117-miljoner-euro-har-tillforts-implantica-utan-ersattning-i-form-av-pengar-eller-aktier/https://www.implantica.com/media/press-releases/2021/bulletin-from-the-extraordinary-general-meeting-in-implantica-ag--assets-of-eur-117-million-have-been-contributed-to-implantica-without-monetary-or-share-compensation/https://www.implantica.com/media/press-releases/2021/implantica-publishes-interim-report-q2-january-june-2021/https://www.implantica.com/media/press-releases/2021/implantica-publicerar-delarsrapporten-q2-januari-juni-2021/https://www.implantica.com/media/press-releases/2021/nyremittering-implantica-meddelar-att-huvudagaren-bidrar-med-tillgangar-pa-117-miljoner-euro-som-ett-kapitaltillskott-till-kapitalreserven/https://www.implantica.com/media/press-releases/2021/resubmission-implantica-announces-contribution-of-assets-of-eur-117-million-by-the-main-shareholder-to-the-capital-reserves/https://www.implantica.com/media/press-releases/2021/notice-of-extraordinary-general-meeting-of-implantica-ag/https://www.implantica.com/media/press-releases/2021/implantica-meddelar-att-huvudagaren-bidrar-med-tillgangar-pa-115-miljoner-euro-som-ett-kapitaltillskott-till-kapitalreserven/https://www.implantica.com/media/press-releases/2021/implantica-meddelar-att-bolaget-kommer-att-fusioneras-med-implantica-mediswiss-ag/https://www.implantica.com/media/press-releases/2021/implantica-announces-contribution-of-assets-of-eur-117-million-by-the-main-shareholder-to-the-capital-reserves/https://www.implantica.com/media/press-releases/2021/implantica-announces-it-will-merge-with-implantica-mediswiss-ag/https://www.implantica.com/media/press-releases/2021/implantica-presents-the-second-quarter-2021-on-august-24-at-1500-cest/https://www.implantica.com/media/press-releases/2021/implantica-presenterar-andra-kvartalet-for-2021-den-24-augusti-kl-1500-cest/https://www.implantica.com/media/press-releases/2021/implantica-appoints-new-experienced-team-to-lead-commercial-operations/https://www.implantica.com/media/press-releases/2021/implantica-utser-ett-nytt-erfaret-team-for-att-leda-den-kommersiella-verksamheten/https://www.implantica.com/media/press-releases/2021/implantica-announces-transition-of-robert-frigg-from-board-of-directors-to-advisory-board/https://www.implantica.com/media/press-releases/2021/implantica-meddelar-att-robert-frigg-flyttar-over-fran-styrelsen-till-det-radgivande-styrelseorganet/https://www.implantica.com/media/press-releases/2021/implantica-announces-that-another-prominent-anti-reflux-center-has-started-operating-with-implantable-medical-device-refluxstop/https://www.implantica.com/media/press-releases/2021/implantica-meddelar-att-ytterligare-ett-framstaende-anti-refluxcenter-har-borjat-operera-med-den-implanterbara-medicintekniska-produkten-refluxstop/https://www.implantica.com/media/press-releases/2021/implantica-achieves-regulatory-authorisation-for-refluxstop-in-new-zealand/https://www.implantica.com/media/press-releases/2021/implantica-erhaller-marknadsauktorisation-for-refluxstop-i-nya-zeeland/https://www.implantica.com/media/press-releases/2021/implantica-strengthens-the-management-team-with-new-vp-qa--ra/https://www.implantica.com/media/press-releases/2021/implantica-forstarker-ledningsgruppen-med-ny-vp-qa--ra/https://www.implantica.com/media/press-releases/2021/implantica-publishes-interim-report-q1-january-march-2021/https://www.implantica.com/media/press-releases/2021/implantica-publicerar-delarsrapporten-q1-januari-mars-2021/https://www.implantica.com/media/press-releases/2021/implantica-presenterar-forsta-kvartalet-for-2021-den-12-maj-kl-1500-cest/https://www.implantica.com/media/press-releases/2021/implantica-presents-the-first-quarter-2021-on-may-12-at-1500-cest/https://www.implantica.com/media/press-releases/2021/bulletin-from-the-annual-general-meeting-in-implantica-ag/https://www.implantica.com/media/press-releases/2021/implantica-har-beslutat-att-ga-vidare-med-en-riktad-nyemission-av-svenska-depabevis-som-tillfor-bolaget-cirka-600-miljoner-sek/https://www.implantica.com/media/press-releases/2021/implantica-has-decided-to-proceed-with-a-private-placement-of-sdrs-raising-gross-proceeds-of-approximately-sek-600-million/https://www.implantica.com/media/press-releases/2021/implantica-avser-genomfora-en-riktad-nyemission-av-svenska-depabevis/https://www.implantica.com/media/press-releases/2021/implantica-contemplates-a-private-placement-of-sdrs/https://www.implantica.com/media/press-releases/2021/notice-of-annual-general-meeting-of-implantica-ag/https://www.implantica.com/media/press-releases/2021/implantica-publishes-annual-report-2020/https://www.implantica.com/media/press-releases/2021/implantica-publicerar-arsredovisning-2020/https://www.implantica.com/media/press-releases/2021/implantica-announces-a-milestone-achieved-for-its-implantable-medical-device-refluxstop/https://www.implantica.com/media/press-releases/2021/implantica-meddelar-att-en-milstolpe-uppnatts-for-deras-medicinska-implantat-refluxstop/https://www.implantica.com/media/press-releases/2021/implantica-makes-headway-in-italy-and-spain-with-its-medical-device-refluxstop/https://www.implantica.com/media/press-releases/2021/implantica-gor-framsteg-i-italien-och-spanien-med-sitt-medicinska-implantat-refluxstop-/https://www.implantica.com/media/press-releases/2021/ceo-peter-forsell-presents-implantica-at-erik-penser-banks-bolagsdag/https://www.implantica.com/media/press-releases/2021/implanticas-medicinska-implantat-refluxstop--tar-ett-kliv-in-i-den-svenska-sjukvarden/https://www.implantica.com/media/press-releases/2021/implantica-advances-in-sweden-with-its-medical-device-refluxstop/https://www.implantica.com/media/press-releases/2021/implantica-publishes-interim-report-q4-january-december-2020/https://www.implantica.com/media/press-releases/2021/implantica-publiserar-interimrapporten-q4-januari-december-2020/https://www.implantica.com/media/press-releases/2021/implantica-presents-the-fourth-quarter-2020-on-february-25-at-1500-cet/https://www.implantica.com/media/press-releases/2021/implantica-presenterar-fjarde-kvartalet-for-2020-den-25-februari-kl-1500-cet/https://www.implantica.com/media/press-releases/2021/implanticas-refluxstop-makes-strides-in-the-uk/https://www.implantica.com/media/press-releases/2021/implanticas-refluxstop-tar-ett-stort-kliv-framat-i-uk/https://www.implantica.com/media/press-releases/2026/implantica-tillkannager-stora-offentliga-upphandlingsvinster-i-italien-som-sakerstaller-over-1-2-miljoner-eur-i-finansiering-for-refluxstop/https://www.implantica.com/media/press-releases/2026/implantica-announces-major-public-tender-wins-in-italy-securing-over-eur-1-2-million-funding-for-refluxstop/https://www.implantica.com/media/press-releases/2026/implantica-presents-the-year-end-report-q4-2025-on-february-25-at-1500-cet/https://www.implantica.com/media/press-releases/2026/implantica-presenterar-bokslutskommunike-q4-2025-den-25-februari-kl-1500-cet/https://www.implantica.com/media/press-releases/2026/implantica-publishes-year-end-report-january-december-2025-q4/https://www.implantica.com/media/press-releases/2026/implantica-publicerar-bokslutskommunike-januari-december-2025-q4/https://www.implantica.com/media/press-releases/2020/implantica-publiserar-interimrapporten-q3-januari-september-2020/https://www.implantica.com/media/press-releases/2020/implantica-publishes-interim-report-q3-january-september-2020/https://www.implantica.com/media/press-releases/2020/implantica-presenterar-tredje-kvartalet-for-2020-den-18-november-kl-1030/https://www.implantica.com/media/press-releases/2020/implantica-presents-the-third-quarter-2020-on-november-18-at-1030-cet/https://www.implantica.com/media/press-releases/2020/implanticas-refluxstop-trial-shows-exceptional-three-year-follow-up-result/https://www.implantica.com/media/press-releases/2020/implanticas-kliniska-provning-av-refluxstop-visar-exceptionella-trearsresultat/https://www.implantica.com/media/press-releases/2020/implantica-files-pre-submission-with-fda-for-refluxstop/https://www.implantica.com/media/press-releases/2020/implantica-lamnar-pre-submission-till-fda-for-refluxstop/https://www.implantica.com/media/press-releases/2020/utnyttjande-av-overtilldelningsoption-i-implantica-och-avslutande-av-stabiliseringsperiod/https://www.implantica.com/media/press-releases/2020/exercise-of-the-overallotment-option-in-implantica-and-end-of-stabilisation-period/https://www.implantica.com/media/press-releases/2021/implantica-inkluderas-i-nasdaq-first-north-25-index/https://www.implantica.com/media/press-releases/2021/implantica-included-in-nasdaq-first-north-25-index/https://www.implantica.com/media/press-releases/2020/andreas-ohrnberg-appointed-new-cfo-of-implantica/https://www.implantica.com/media/press-releases/2020/implantica-announces-liselott-kilaas-as-new-chairman/https://www.implantica.com/media/press-releases/2020/annual-general-meeting-of-shareholders-of-implantica-mediswiss-ag/https://www.implantica.com/media/press-releases/2020/implanticas-refluxstop-1-year-results-published-in-BMC-Surgery/https://www.implantica.com/media/press-releases/2020/utnyttjande-av-overtilldelningsoption-i-implantica-och-avslutande-av-stabiliseringsperiod-A/https://www.implantica.com/media/press-releases/2018/implantica-receives-ce-mark-approval-for-refluxstop-a-potential-paradigm-shift-in-the-treatment-for-acid-reflux/https://www.implantica.com/media/subscribe/https://www.implantica.com/media/media-and-events/https://www.implantica.com/media/media-and-events/2025/lucy-mayer-talks-to-refluxstop-patient/https://www.implantica.com/media/media-and-events/2025/refluxstop-featured-in-the-daily-mail/https://www.implantica.com/media/media-and-events/2024/bbc-radio-tees-interview-with-mr-nick-boyle-of-refluxuk-discusses-innovative-treatment-for-gerd/https://www.implantica.com/media/media-and-events/2024/dr-leonardo-vincenti-discusses-refluxstop-on-telenorba-morning-news/https://www.implantica.com/media/media-and-events/2024/first-refluxstop-meeting-held-in-spain/https://www.implantica.com/media/media-and-events/2024/refluxstop-featured-on-bbc/https://www.implantica.com/media/media-and-events/2024/implantica-announces-further-expansion-of-refluxstop-access-in-the-uk-nhs-public-hospital-network/https://www.implantica.com/media/media-and-events/2024/refluxstop-featured-in-the-independent/https://www.implantica.com/media/media-and-events/2024/doctors-daniel-sanchez-and-pablo-priego-discuss-how-refluxstop-works/https://www.implantica.com/media/media-and-events/2023/refluxstop-patient-on-bbc-radio-leicester/https://www.implantica.com/media/media-and-events/2023/peter-forsell-to-present-at-pareto-securities-healthcare-conference-on-september-14/https://www.implantica.com/media/media-and-events/2023/refluxstop-patient-in-the-daily-mail-online/https://www.implantica.com/media/media-and-events/2023/implantica-ceo-peter-forsell-presents-at-redeye-future-of-healthcare-event/https://www.implantica.com/media/media-and-events/2023/refluxstop-wins-medtops-most-innovative-device-category/https://www.implantica.com/media/media-and-events/2023/dr-peter-forsell-ceo-of-implantica-named-10-best-ceos-to-watch-2023/https://www.implantica.com/media/media-and-events/2023/bbc-radio-interview-with-renowned-surgeon-paul-goldsmith-and-patient-david-walsh/https://www.implantica.com/media/media-and-events/2023/implantica-capital-markets-day-2023/https://www.implantica.com/media/media-and-events/2023/implantica-honored-with-innovation-excellence-award/https://www.implantica.com/media/media-and-events/2023/refluxstop-featured-in-saga-magazine/https://www.implantica.com/media/media-and-events/2023/refluxstop-in-the-daily-mirror/https://www.implantica.com/media/media-and-events/2023/refluxstop-featured-in-the-daily-express/https://www.implantica.com/media/media-and-events/2023/refluxstop-in-readers-digest-uk/https://www.implantica.com/media/media-and-events/2023/prof-juan-carlos-ruiz-de-adana-hospital-getafe-discusses-refluxstop-with-cadena-ser/https://www.implantica.com/media/media-and-events/2023/getafe-university-hospital-is-the-first-spanish-center-selected-to-perform-refluxstop/https://www.implantica.com/media/media-and-events/2023/refluxstop-featured-on-sky-news/https://www.implantica.com/media/media-and-events/2023/peter-forsell-implantica-ceo-featured-on-medtech-insight/https://www.implantica.com/media/media-and-events/2023/mr-ahmed-r-ahmed-one-of-londons-leading-general-laparoscopic-gastrointestinal-and-bariatric-surgeons-discusses-refluxstop/https://www.implantica.com/media/media-and-events/2022/interview-with-peter-forsell/https://www.implantica.com/media/media-and-events/2021/implantica-showcase/https://www.implantica.com/media/media-and-events/2021/refluxchirurgie-gibt-es-endlich-eine-neue-operative-alternative-zur-fundoplikatio/https://www.implantica.com/media/media-and-events/2021/die-borse-ist-mit-implantica-um-einen-medizintechnik-wert-reicher/https://www.implantica.com/media/media-and-events/2021/peter-forsells-presentation-at-erik-penser-banks-bolagsdag/https://www.implantica.com/media/media-and-events/2020/telezuri-checkup/https://www.implantica.com/media/media-and-events/2020/listing-first-north/https://www.implantica.com/media/media-and-events/2020/medtechfirma-geht-an-die-borse/https://www.implantica.com/media/media-and-events/2020/listing-of-implantica/https://www.implantica.com/media/media-and-events/2020/article-on-implantica-and-peter-forsell/https://www.implantica.com/media/media-and-events/2020/broadcast-featuring-implantica-ipo/https://www.implantica.com/media/media-and-events/2020/interview-peter-forsell-ceo-implantica/https://www.implantica.com/media/media-and-events/2020/robert-triches-on-the-listing-of-implantica/https://www.implantica.com/media/media-and-events/2020/medtech-companies-aim-high-record-listing-close/https://www.implantica.com/media/media-and-events/2020/peter-forsell-the-surgeon-who-became-a-billionaire/https://www.implantica.com/media/media-and-events/2020/swiss-medtech-company-scorns-the-local-stock-exchange/https://www.implantica.com/media/image-bank/https://www.implantica.com/media/media-contact/https://www.implantica.com/media/media-kit/https://www.implantica.com/investors/https://www.implantica.com/investors/financial-calendar/https://www.implantica.com/investors/financial-calendar/2023/annual-report-2022-20-april-2023/https://www.implantica.com/investors/financial-reports/https://www.implantica.com/investors/financial-reports/implantica-publicerar-delarsrapporten-q1-januari-mars-2021/https://www.implantica.com/investors/financial-reports/implantica-publishes-interim-report-q3-january-september-2020/https://www.implantica.com/investors/financial-reports/implantica-publishes-interim-report-q3-2022/https://www.implantica.com/investors/financial-reports/implantica-publicerar-delarsrapporten-q2-januari-juni-2021/https://www.implantica.com/investors/financial-reports/implantica-publishes-interim-report-q3-january-september-2021/https://www.implantica.com/investors/financial-reports/implantica-publicerar-delarsrapport-q3-2022/https://www.implantica.com/investors/financial-reports/implantica-publishes-interim-report-q4-january-december-2020/https://www.implantica.com/investors/financial-reports/implantica-publishes-interim-report-q1-january-march-2021/https://www.implantica.com/investors/financial-reports/implantica-publishes-interim-report-q1-january--march-2022/https://www.implantica.com/investors/financial-reports/implantica-publicerar-delarsrapport-q2-2022/https://www.implantica.com/investors/financial-reports/implantica-publicerar-delarsrapporten-q3-januari-september-2021/https://www.implantica.com/investors/financial-reports/implantica-publicerar-bokslutskommunike--januari-december-2022-q4/https://www.implantica.com/investors/financial-reports/implantica-publicerar-bokslutskommunike-januari-december-2021/https://www.implantica.com/investors/financial-reports/implantica-publishes-interim-report-january--june-2023-q2/https://www.implantica.com/investors/financial-reports/implantica-publicerar-arsredovisning-2022/https://www.implantica.com/investors/financial-reports/implantica-publishes-annual-report-2022/https://www.implantica.com/investors/financial-reports/implantica-publicerar-bokslutskommunike--januari-december-2023-q4/https://www.implantica.com/investors/financial-reports/implantica-publicerar-delarsrapport-januari--mars-2024-q1/https://www.implantica.com/investors/financial-reports/implantica-publicerar-delarsrapporten-q1-januari-mars-2022/https://www.implantica.com/investors/financial-reports/implantica-publishes-interim-report-january-june-2024-q2/https://www.implantica.com/investors/financial-reports/implantica-publishes-year-end-report-january-december-2021/https://www.implantica.com/investors/financial-reports/implantica-publicerar-delarsrapport-januari--september-2024-q3/https://www.implantica.com/investors/financial-reports/implantica-publicerar-delarsrapport-januari--juni-2024-q2/https://www.implantica.com/investors/financial-reports/implantica-publishes-interim-report-january-september-2024-q3/https://www.implantica.com/investors/financial-reports/implantica-publishes-interim-report-q2-2022/https://www.implantica.com/investors/financial-reports/implantica-publiserar-interimrapporten-q4-januari-december-2020/https://www.implantica.com/investors/financial-reports/implantica-publicerar-arsredovisning-2020/https://www.implantica.com/investors/financial-reports/implantica-publishes-annual-report-2020/https://www.implantica.com/investors/financial-reports/implantica-publiserar-interimrapporten-q3-januari-september-2020/https://www.implantica.com/investors/financial-reports/implantica-publishes-year-end-report-january--december-2022-q4/https://www.implantica.com/investors/financial-reports/implantica-publishes-year-end-report-january-december-2023-q4/https://www.implantica.com/investors/financial-reports/implantica-publishes-interim-report-q2-january-june-2021/https://www.implantica.com/investors/financial-reports/implantica-publicerar-delarsrapport-januari---mars-2023-q1/https://www.implantica.com/investors/financial-reports/implantica-publishes-interim-report-january--march-2023-q1/https://www.implantica.com/investors/financial-reports/implantica-publishes-interim-report-january-march-2024-q1/https://www.implantica.com/investors/financial-reports/implantica-publishes-interim-report-january--september-2023-q3/https://www.implantica.com/investors/financial-reports/implantica-publicerar-delarsrapport-januari---september-2023-q3/https://www.implantica.com/investors/financial-reports/implantica-publishes-annual-report-2023/https://www.implantica.com/investors/financial-reports/implantica-mediswiss-consolidated-annual-report-2018/https://www.implantica.com/investors/financial-reports/implantica-mediswiss-consolidated-annual-report-2017/https://www.implantica.com/investors/financial-reports/implantica-ag-consolidated-interim-report-2020/https://www.implantica.com/investors/financial-reports/implantica-mediswiss-consolidated-annual-report-2019/https://www.implantica.com/investors/financial-reports/implantica-publicerar-bokslutskommunike-januari-december-2024-q4/https://www.implantica.com/investors/financial-reports/implantica-publishes-year-end-report-january-december-2024-q4/https://www.implantica.com/investors/financial-reports/implantica-publishes-annual-report-2024/https://www.implantica.com/investors/financial-reports/implantica-publishes-interim-report-january-march-2025-q1/https://www.implantica.com/investors/financial-reports/implantica-publicerar-delarsrapport-januari--mars-2025-q1/https://www.implantica.com/investors/financial-reports/implantica-publishes-interim-report-january-june-2025-q2/https://www.implantica.com/investors/financial-reports/implantica-publicerar-delarsrapport-januari--juni-2025-q2/https://www.implantica.com/investors/financial-reports/implantica-publishes-interim-report-january-september-2025-q3/https://www.implantica.com/investors/financial-reports/implantica-publicerar-delarsrapport-januari--september-2025-q3/https://www.implantica.com/investors/financial-reports/implantica-publishes-year-end-report-january-december-2025-q4/https://www.implantica.com/investors/financial-reports/implantica-publicerar-bokslutskommunike-januari-december-2025-q4/https://www.implantica.com/investors/financial-reports/implantica-publishes-annual-report-2021/https://www.implantica.com/investors/share/the-share/https://www.implantica.com/investors/share/certified-advisor/https://www.implantica.com/investors/share/analyst-coverage/https://www.implantica.com/investors/corporate-governance/board-of-directors/https://www.implantica.com/investors/corporate-governance/management/https://www.implantica.com/investors/corporate-governance/renumeration--incentive-program/https://www.implantica.com/investors/corporate-governance/annual-general-meeting/https://www.implantica.com/investors/corporate-governance/board-committees/https://www.implantica.com/investors/corporate-governance/commercial-register/https://www.implantica.com/investors/corporate-governance/articles-of-association/https://www.implantica.com/investors/investor-relations/https://www.implantica.com/us/https://www.implantica.com/us/im-refluxstop/https://www.implantica.com/us/im-refluxstop/patients/gastrointestinal/https://www.implantica.com/us/im-refluxstop/professionals/gastrointestinal/https://www.implantica.com/us/im-refluxstop/scientific-publications-and-abstracts/https://www.implantica.com/us/product-pipeline/prioritized-products/https://www.implantica.com/us/product-pipeline/prioritized-products/urology/urinary-incontinence/https://www.implantica.com/us/product-pipeline/prioritized-products/gastrointestinal/obesity/https://www.implantica.com/us/product-pipeline/prioritized-products/ehealth/e-invivo/https://www.implantica.com/us/product-pipeline/follow-on-products/https://www.implantica.com/us/product-pipeline/follow-on-products/urology/urinary-retention/https://www.implantica.com/us/product-pipeline/follow-on-products/urology/erectile-dysfunction/https://www.implantica.com/us/product-pipeline/follow-on-products/gastrointestinal/ostomy/https://www.implantica.com/us/product-pipeline/follow-on-products/gastrointestinal/fecal-incontinence-stoma/https://www.implantica.com/us/product-pipeline/follow-on-products/ehealth/aorta-aneurysm/https://www.implantica.com/us/product-pipeline/future-pipeline-ip/https://www.implantica.com/us/innovations/technology-platform-overview/https://www.implantica.com/us/innovations/implantable-ehealth-platform/https://www.implantica.com/us/innovations/wireless-energizing-platform/https://www.implantica.com/us/innovations/patent-portfolio/https://www.implantica.com/us/about-implantica/company-profile/https://www.implantica.com/us/about-implantica/founder/https://www.implantica.com/us/about-implantica/board-of-directors/https://www.implantica.com/us/about-implantica/executive-management/https://www.implantica.com/us/about-implantica/mission-vision/https://www.implantica.com/us/about-implantica/sustainability/https://www.implantica.com/us/about-implantica/track-record/https://www.implantica.com/us/about-implantica/careers/https://www.implantica.com/us/about-implantica/contact/https://www.implantica.com/us/about-implantica/legal-notices/data-privacy/https://www.implantica.com/us/about-implantica/legal-notices/imprint/https://www.implantica.com/us/about-implantica/legal-notices/disclaimer/https://www.implantica.com/us/about-implantica/legal-notices/t-and-c/https://www.implantica.com/us/news-events/press-releases/https://www.implantica.com/us/news-events/press-releases/release/https://www.implantica.com/us/news-events/subscribe/https://www.implantica.com/us/news-events/media-and-events/https://www.implantica.com/us/news-events/media-and-events/2025/lucy-mayer-talks-to-refluxstop-patient/https://www.implantica.com/us/news-events/media-and-events/2025/refluxstop-featured-in-the-daily-mail/https://www.implantica.com/us/news-events/media-and-events/2024/bbc-radio-tees-interview-with-mr-nick-boyle-of-refluxuk-discusses-innovative-treatment-for-gerd/https://www.implantica.com/us/news-events/media-and-events/2024/dr-leonardo-vincenti-discusses-refluxstop-on-telenorba-morning-news/https://www.implantica.com/us/news-events/media-and-events/2024/first-refluxstop-meeting-held-in-spain/https://www.implantica.com/us/news-events/media-and-events/2024/refluxstop-featured-on-bbc/https://www.implantica.com/us/news-events/media-and-events/2024/implantica-announces-further-expansion-of-refluxstop-access-in-the-uk-nhs-public-hospital-network/https://www.implantica.com/us/news-events/media-and-events/2024/refluxstop-featured-in-the-independent/https://www.implantica.com/us/news-events/media-and-events/2024/doctors-daniel-sanchez-and-pablo-priego-discuss-how-refluxstop-works/https://www.implantica.com/us/news-events/media-and-events/2023/refluxstop-patient-on-bbc-radio-leicester/https://www.implantica.com/us/news-events/media-and-events/2023/peter-forsell-to-present-at-pareto-securities-healthcare-conference-on-september-14/https://www.implantica.com/us/news-events/media-and-events/2023/refluxstop-patient-in-the-daily-mail-online/https://www.implantica.com/us/news-events/media-and-events/2023/implantica-ceo-peter-forsell-presents-at-redeye-future-of-healthcare-event/https://www.implantica.com/us/news-events/media-and-events/2023/refluxstop-wins-medtops-most-innovative-device-category/https://www.implantica.com/us/news-events/media-and-events/2023/dr-peter-forsell-ceo-of-implantica-named-10-best-ceos-to-watch-2023/https://www.implantica.com/us/news-events/media-and-events/2023/bbc-radio-interview-with-renowned-surgeon-paul-goldsmith-and-patient-david-walsh/https://www.implantica.com/us/news-events/media-and-events/2023/implantica-capital-markets-day-2023/https://www.implantica.com/us/news-events/media-and-events/2023/implantica-honored-with-innovation-excellence-award/https://www.implantica.com/us/news-events/media-and-events/2023/refluxstop-featured-in-saga-magazine/https://www.implantica.com/us/news-events/media-and-events/2023/refluxstop-in-the-daily-mirror/https://www.implantica.com/us/news-events/media-and-events/2023/refluxstop-featured-in-the-daily-express/https://www.implantica.com/us/news-events/media-and-events/2023/refluxstop-in-readers-digest-uk/https://www.implantica.com/us/news-events/media-and-events/2023/prof-juan-carlos-ruiz-de-adana-hospital-getafe-discusses-refluxstop-with-cadena-ser/https://www.implantica.com/us/news-events/media-and-events/2023/getafe-university-hospital-is-the-first-spanish-center-selected-to-perform-refluxstop/https://www.implantica.com/us/news-events/media-and-events/2023/refluxstop-featured-on-sky-news/https://www.implantica.com/us/news-events/media-and-events/2023/peter-forsell-implantica-ceo-featured-on-medtech-insight/https://www.implantica.com/us/news-events/media-and-events/2023/mr-ahmed-r-ahmed-one-of-londons-leading-general-laparoscopic-gastrointestinal-and-bariatric-surgeons-discusses-refluxstop/https://www.implantica.com/us/news-events/media-and-events/2022/interview-with-peter-forsell/https://www.implantica.com/us/news-events/media-and-events/2021/implantica-showcase/https://www.implantica.com/us/news-events/media-and-events/2021/refluxchirurgie-gibt-es-endlich-eine-neue-operative-alternative-zur-fundoplikatio/https://www.implantica.com/us/news-events/media-and-events/2021/die-borse-ist-mit-implantica-um-einen-medizintechnik-wert-reicher/https://www.implantica.com/us/news-events/media-and-events/2021/peter-forsells-presentation-at-erik-penser-banks-bolagsdag/https://www.implantica.com/us/news-events/media-and-events/2020/telezuri-checkup/https://www.implantica.com/us/news-events/media-and-events/2020/listing-first-north/https://www.implantica.com/us/news-events/media-and-events/2020/medtechfirma-geht-an-die-borse/https://www.implantica.com/us/news-events/media-and-events/2020/listing-of-implantica/https://www.implantica.com/us/news-events/media-and-events/2020/article-on-implantica-and-peter-forsell/https://www.implantica.com/us/news-events/media-and-events/2020/broadcast-featuring-implantica-ipo/https://www.implantica.com/us/news-events/media-and-events/2020/interview-peter-forsell-ceo-implantica/https://www.implantica.com/us/news-events/media-and-events/2020/robert-triches-on-the-listing-of-implantica/https://www.implantica.com/us/news-events/media-and-events/2020/medtech-companies-aim-high-record-listing-close/https://www.implantica.com/us/news-events/media-and-events/2020/peter-forsell-the-surgeon-who-became-a-billionaire/https://www.implantica.com/us/news-events/media-and-events/2020/swiss-medtech-company-scorns-the-local-stock-exchange/https://www.implantica.com/us/news-events/image-bank/https://www.implantica.com/us/news-events/media-contact/https://www.implantica.com/us/news-events/media-kit/https://www.implantica.com/us/investors/https://www.implantica.com/us/investors/financial-calendar/https://www.implantica.com/us/investors/financial-calendar/2023/annual-report-2022-20-april-2023/https://www.implantica.com/us/investors/financial-reports/https://www.implantica.com/us/investors/financial-reports/implantica-publicerar-delarsrapporten-q3-januari-september-2021/https://www.implantica.com/us/investors/financial-reports/implantica-publicerar-delarsrapporten-q1-januari-mars-2022/https://www.implantica.com/us/investors/financial-reports/implantica-publishes-annual-report-2020/https://www.implantica.com/us/investors/financial-reports/implantica-publishes-interim-report-q1-january-march-2021/https://www.implantica.com/us/investors/financial-reports/implantica-publicerar-delarsrapport-q2-2022/https://www.implantica.com/us/investors/financial-reports/implantica-publishes-interim-report-q3-2022/https://www.implantica.com/us/investors/financial-reports/implantica-publishes-interim-report-january-june-2024-q2/https://www.implantica.com/us/investors/financial-reports/implantica-publicerar-delarsrapport-januari--juni-2024-q2/https://www.implantica.com/us/investors/financial-reports/implantica-publishes-interim-report-january-september-2024-q3/https://www.implantica.com/us/investors/financial-reports/implantica-publicerar-delarsrapport-q3-2022/https://www.implantica.com/us/investors/financial-reports/implantica-publiserar-interimrapporten-q3-januari-september-2020/https://www.implantica.com/us/investors/financial-reports/implantica-publishes-interim-report-q3-january-september-2020/https://www.implantica.com/us/investors/financial-reports/implantica-publishes-interim-report-q3-january-september-2021/https://www.implantica.com/us/investors/financial-reports/implantica-publiserar-interimrapporten-q4-januari-december-2020/https://www.implantica.com/us/investors/financial-reports/implantica-publishes-year-end-report-january-december-2021/https://www.implantica.com/us/investors/financial-reports/implantica-publicerar-delarsrapporten-q1-januari-mars-2021/https://www.implantica.com/us/investors/financial-reports/implantica-publishes-year-end-report-january-december-2023-q4/https://www.implantica.com/us/investors/financial-reports/implantica-publishes-year-end-report-january-december-2024-q4/https://www.implantica.com/us/investors/financial-reports/implantica-publishes-interim-report-january--march-2023-q1/https://www.implantica.com/us/investors/financial-reports/implantica-publicerar-arsredovisning-2022/https://www.implantica.com/us/investors/financial-reports/implantica-publicerar-delarsrapport-januari---september-2023-q3/https://www.implantica.com/us/investors/financial-reports/implantica-publicerar-delarsrapport-januari--september-2024-q3/https://www.implantica.com/us/investors/financial-reports/implantica-publishes-year-end-report-january--december-2022-q4/https://www.implantica.com/us/investors/financial-reports/implantica-publicerar-bokslutskommunike-januari-december-2021/https://www.implantica.com/us/investors/financial-reports/implantica-publishes-interim-report-q2-january-june-2021/https://www.implantica.com/us/investors/financial-reports/implantica-publishes-interim-report-q1-january--march-2022/https://www.implantica.com/us/investors/financial-reports/implantica-publishes-interim-report-q2-2022/https://www.implantica.com/us/investors/financial-reports/implantica-publicerar-bokslutskommunike--januari-december-2022-q4/https://www.implantica.com/us/investors/financial-reports/implantica-publicerar-bokslutskommunike-januari-december-2024-q4/https://www.implantica.com/us/investors/financial-reports/implantica-publishes-interim-report-january--september-2023-q3/https://www.implantica.com/us/investors/financial-reports/implantica-publicerar-bokslutskommunike--januari-december-2023-q4/https://www.implantica.com/us/investors/financial-reports/implantica-publicerar-arsredovisning-2020/https://www.implantica.com/us/investors/financial-reports/implantica-publicerar-delarsrapporten-q2-januari-juni-2021/https://www.implantica.com/us/investors/financial-reports/implantica-publishes-interim-report-q4-january-december-2020/https://www.implantica.com/us/investors/financial-reports/implantica-publishes-annual-report-2022/https://www.implantica.com/us/investors/financial-reports/implantica-publicerar-delarsrapport-januari--mars-2024-q1/https://www.implantica.com/us/investors/financial-reports/implantica-publicerar-delarsrapport-januari---mars-2023-q1/https://www.implantica.com/us/investors/financial-reports/implantica-publishes-interim-report-january--june-2023-q2/https://www.implantica.com/us/investors/financial-reports/implantica-publishes-annual-report-2023/https://www.implantica.com/us/investors/financial-reports/implantica-publishes-interim-report-january-march-2024-q1/https://www.implantica.com/us/investors/financial-reports/implantica-mediswiss-consolidated-annual-report-2018/https://www.implantica.com/us/investors/financial-reports/implantica-mediswiss-consolidated-annual-report-2017/https://www.implantica.com/us/investors/financial-reports/implantica-ag-consolidated-interim-report-2020/https://www.implantica.com/us/investors/financial-reports/implantica-mediswiss-consolidated-annual-report-2019/https://www.implantica.com/us/investors/financial-reports/implantica-publishes-annual-report-2021/https://www.implantica.com/us/investors/financial-reports/implantica-publishes-annual-report-2024/https://www.implantica.com/us/investors/financial-reports/implantica-publishes-interim-report-january-march-2025-q1/https://www.implantica.com/us/investors/financial-reports/implantica-publicerar-delarsrapport-januari--mars-2025-q1/https://www.implantica.com/us/investors/financial-reports/implantica-publishes-interim-report-january-june-2025-q2/https://www.implantica.com/us/investors/financial-reports/implantica-publicerar-delarsrapport-januari--juni-2025-q2/https://www.implantica.com/us/investors/financial-reports/implantica-publishes-interim-report-january-september-2025-q3/https://www.implantica.com/us/investors/financial-reports/implantica-publicerar-delarsrapport-januari--september-2025-q3/https://www.implantica.com/us/investors/financial-reports/implantica-publishes-year-end-report-january-december-2025-q4/https://www.implantica.com/us/investors/financial-reports/implantica-publicerar-bokslutskommunike-januari-december-2025-q4/https://www.implantica.com/us/investors/share/the-share/https://www.implantica.com/us/investors/share/certified-advisor/https://www.implantica.com/us/investors/share/analyst-coverage/https://www.implantica.com/us/investors/corporate-governance/board-of-directors/https://www.implantica.com/us/investors/corporate-governance/management/https://www.implantica.com/us/investors/corporate-governance/renumeration-incentive-program/https://www.implantica.com/us/investors/corporate-governance/annual-general-meeting/https://www.implantica.com/us/investors/corporate-governance/board-committees/https://www.implantica.com/us/investors/corporate-governance/commercial-register/https://www.implantica.com/us/investors/corporate-governance/articles-of-association/https://www.implantica.com/us/investors/corporate-governance/executive-management/https://www.implantica.com/us/investors/investor-relations/https://www.implantica.com/us/page-not-found/https://www.implantica.com/us/page-footer-us/https://www.implantica.com/us/search/